Related Experiment Video
Updated: Feb 5, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia
Chengcheng He1,2, Bo Luo2, Nan Jiang2
1a People's Hospital of Zhongjiang , Deyang , Sichuan , P. R. China.
Abstract:
Acute Myeloid Leukemia (AML) is a hematopoietic progenitor/stem cell disorder in which neoplastic myeloblasts are stopped at an immature stage of differentiation and lost the normal ability of proliferation and apoptosis. MicroRNAs (miRNAs) are small noncoding, single-stranded RNA molecules that can mediate the expression of target genes. While miRNAs mean to contribute the developments of normal functions, abnormal expression of miRNAs and regulations on their corresponding targets have often been found in the developments of AML and described in recent years. In leukemia, miRNAs may function as regulatory molecules, acting as oncogenes or tumor suppressors. Overexpression of miRNAs can down-regulate tumor suppressors or other genes involved in cell differentiation, thereby contributing to AML formation. Similarly, miRNAs can down-regulate different proteins with oncogenic activity as tumor suppressors. We herein review the current data on miRNAs, specifically their targets and their biological function based on apoptosis in the development of AML.
Insights
MicroRNAs (miRNAs) play a dual role in Acute Myeloid Leukemia (AML), acting as oncogenes or tumor suppressors. Their abnormal expression impacts cell differentiation and apoptosis, contributing to AML development.
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- Acute Myeloid Leukemia (AML) is a stem cell disorder characterized by immature myeloblasts with impaired proliferation and apoptosis.
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
- Aberrant miRNA expression is increasingly recognized in AML pathogenesis.
Purpose of the Study:
- To review current data on miRNAs in Acute Myeloid Leukemia (AML).
- To explore the specific targets and biological functions of miRNAs, particularly concerning apoptosis in AML development.
Main Methods:
- Literature review of existing research on miRNAs, their targets, and their role in AML.
- Analysis of biological functions, focusing on apoptosis regulation by miRNAs in the context of leukemia.
Main Results:
- miRNAs can function as oncogenes or tumor suppressors in leukemia.
- Overexpressed miRNAs can down-regulate tumor suppressors, hindering cell differentiation and promoting AML.
- Conversely, miRNAs can act as tumor suppressors by down-regulating oncogenic proteins.
Conclusions:
- miRNAs are critical regulatory molecules in Acute Myeloid Leukemia.
- Understanding miRNA targets and their impact on apoptosis is crucial for deciphering AML development.
- miRNAs represent potential therapeutic targets for AML treatment.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Related Concept Videos
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Differentiation of Common Myeloid Progenitor Cells
Role-Based Identity
Role of Hippocampus in Memory
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: